Bacterial infections in adult patients hospitalized with AIDS: Case- control study of prophylactic efficacy of trimethoprim-sulfamethoxazole versus aerosolized pentamidine

Stephen R. Tabet, Melissa R. Krone, Thomas Hooton, Laura A. Koutsky, King K. Holmes

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

To determine the association between trimethoprim-sulfamethoxazole (TMP- SMX) prophylaxis for Pneumoctystis carinii pneumonia and risk of bacterial infections in persons with AIDS, we abstracted hospital records from 6496 adult admissions to 42 hospitals in western Washington state. Of these admissions, 570 involved 637 bacterial infections diagnosed among patients who had been prescribed prophylactic TMP-SMX or aerosolized pentamidine. Cases [admissions with bacteraemia, bacterial pneumonia, acute or chronic sinusitis, or urinary tract infection (UTI)] were compared to controls (admissions not associated with any of the 5 bacterial infections). After adjusting for CD4 lymphocyte count and presence of P. carinii pneumoma, TMP- SMX prophylaxis, relative to aerosolized pentamidine prophylaxis, was associated with a reduced risk of bacteraemia (adjusted OR=0.5; 95% CI, 0.2- 1.0; P=0.04), bacterial pneumonia (adjusted OR=0.5; 95% CI, 0.3-0.8; P=0.01), acute sinusitis (adjusted OR=0.5; 95% CI, 0.2-1.3: P=0.2), chronic sinusitis (adjusted OR=0.3; 95% CL 0.1-0.7; P=0.01), and UTI (adjusted OR=0.5; 95% CI, 0.2-1.2; P=0.1), and all 5 bacterial infections combined (adjusted OR=0.6; 95% CI, 0.5-0.8; P<0.001).

Original languageEnglish
Pages (from-to)563-569
Number of pages7
JournalInternational Journal of STD and AIDS
Volume8
Issue number9
DOIs
StatePublished - Sep 10 1997
Externally publishedYes

Fingerprint

Pentamidine
Sulfamethoxazole Drug Combination Trimethoprim
Bacterial Infections
Case-Control Studies
Sinusitis
Acquired Immunodeficiency Syndrome
Bacterial Pneumonia
Bacteremia
Urinary Tract Infections
Hospital Records
CD4 Lymphocyte Count
Pneumonia

Keywords

  • Bacteraemia
  • Bacterial infections
  • Bacterial pneumonia
  • HIV/AIDS
  • Sinusitis
  • Trimethoprim-sulfamethoxazole
  • Urinary tract infection

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)
  • Immunology

Cite this

Bacterial infections in adult patients hospitalized with AIDS : Case- control study of prophylactic efficacy of trimethoprim-sulfamethoxazole versus aerosolized pentamidine. / Tabet, Stephen R.; Krone, Melissa R.; Hooton, Thomas; Koutsky, Laura A.; Holmes, King K.

In: International Journal of STD and AIDS, Vol. 8, No. 9, 10.09.1997, p. 563-569.

Research output: Contribution to journalArticle

@article{c25a9040a4f14028891d9a97fa38de5b,
title = "Bacterial infections in adult patients hospitalized with AIDS: Case- control study of prophylactic efficacy of trimethoprim-sulfamethoxazole versus aerosolized pentamidine",
abstract = "To determine the association between trimethoprim-sulfamethoxazole (TMP- SMX) prophylaxis for Pneumoctystis carinii pneumonia and risk of bacterial infections in persons with AIDS, we abstracted hospital records from 6496 adult admissions to 42 hospitals in western Washington state. Of these admissions, 570 involved 637 bacterial infections diagnosed among patients who had been prescribed prophylactic TMP-SMX or aerosolized pentamidine. Cases [admissions with bacteraemia, bacterial pneumonia, acute or chronic sinusitis, or urinary tract infection (UTI)] were compared to controls (admissions not associated with any of the 5 bacterial infections). After adjusting for CD4 lymphocyte count and presence of P. carinii pneumoma, TMP- SMX prophylaxis, relative to aerosolized pentamidine prophylaxis, was associated with a reduced risk of bacteraemia (adjusted OR=0.5; 95{\%} CI, 0.2- 1.0; P=0.04), bacterial pneumonia (adjusted OR=0.5; 95{\%} CI, 0.3-0.8; P=0.01), acute sinusitis (adjusted OR=0.5; 95{\%} CI, 0.2-1.3: P=0.2), chronic sinusitis (adjusted OR=0.3; 95{\%} CL 0.1-0.7; P=0.01), and UTI (adjusted OR=0.5; 95{\%} CI, 0.2-1.2; P=0.1), and all 5 bacterial infections combined (adjusted OR=0.6; 95{\%} CI, 0.5-0.8; P<0.001).",
keywords = "Bacteraemia, Bacterial infections, Bacterial pneumonia, HIV/AIDS, Sinusitis, Trimethoprim-sulfamethoxazole, Urinary tract infection",
author = "Tabet, {Stephen R.} and Krone, {Melissa R.} and Thomas Hooton and Koutsky, {Laura A.} and Holmes, {King K.}",
year = "1997",
month = "9",
day = "10",
doi = "10.1258/0956462971920794",
language = "English",
volume = "8",
pages = "563--569",
journal = "International Journal of STD and AIDS",
issn = "0956-4624",
publisher = "SAGE Publications Ltd",
number = "9",

}

TY - JOUR

T1 - Bacterial infections in adult patients hospitalized with AIDS

T2 - Case- control study of prophylactic efficacy of trimethoprim-sulfamethoxazole versus aerosolized pentamidine

AU - Tabet, Stephen R.

AU - Krone, Melissa R.

AU - Hooton, Thomas

AU - Koutsky, Laura A.

AU - Holmes, King K.

PY - 1997/9/10

Y1 - 1997/9/10

N2 - To determine the association between trimethoprim-sulfamethoxazole (TMP- SMX) prophylaxis for Pneumoctystis carinii pneumonia and risk of bacterial infections in persons with AIDS, we abstracted hospital records from 6496 adult admissions to 42 hospitals in western Washington state. Of these admissions, 570 involved 637 bacterial infections diagnosed among patients who had been prescribed prophylactic TMP-SMX or aerosolized pentamidine. Cases [admissions with bacteraemia, bacterial pneumonia, acute or chronic sinusitis, or urinary tract infection (UTI)] were compared to controls (admissions not associated with any of the 5 bacterial infections). After adjusting for CD4 lymphocyte count and presence of P. carinii pneumoma, TMP- SMX prophylaxis, relative to aerosolized pentamidine prophylaxis, was associated with a reduced risk of bacteraemia (adjusted OR=0.5; 95% CI, 0.2- 1.0; P=0.04), bacterial pneumonia (adjusted OR=0.5; 95% CI, 0.3-0.8; P=0.01), acute sinusitis (adjusted OR=0.5; 95% CI, 0.2-1.3: P=0.2), chronic sinusitis (adjusted OR=0.3; 95% CL 0.1-0.7; P=0.01), and UTI (adjusted OR=0.5; 95% CI, 0.2-1.2; P=0.1), and all 5 bacterial infections combined (adjusted OR=0.6; 95% CI, 0.5-0.8; P<0.001).

AB - To determine the association between trimethoprim-sulfamethoxazole (TMP- SMX) prophylaxis for Pneumoctystis carinii pneumonia and risk of bacterial infections in persons with AIDS, we abstracted hospital records from 6496 adult admissions to 42 hospitals in western Washington state. Of these admissions, 570 involved 637 bacterial infections diagnosed among patients who had been prescribed prophylactic TMP-SMX or aerosolized pentamidine. Cases [admissions with bacteraemia, bacterial pneumonia, acute or chronic sinusitis, or urinary tract infection (UTI)] were compared to controls (admissions not associated with any of the 5 bacterial infections). After adjusting for CD4 lymphocyte count and presence of P. carinii pneumoma, TMP- SMX prophylaxis, relative to aerosolized pentamidine prophylaxis, was associated with a reduced risk of bacteraemia (adjusted OR=0.5; 95% CI, 0.2- 1.0; P=0.04), bacterial pneumonia (adjusted OR=0.5; 95% CI, 0.3-0.8; P=0.01), acute sinusitis (adjusted OR=0.5; 95% CI, 0.2-1.3: P=0.2), chronic sinusitis (adjusted OR=0.3; 95% CL 0.1-0.7; P=0.01), and UTI (adjusted OR=0.5; 95% CI, 0.2-1.2; P=0.1), and all 5 bacterial infections combined (adjusted OR=0.6; 95% CI, 0.5-0.8; P<0.001).

KW - Bacteraemia

KW - Bacterial infections

KW - Bacterial pneumonia

KW - HIV/AIDS

KW - Sinusitis

KW - Trimethoprim-sulfamethoxazole

KW - Urinary tract infection

UR - http://www.scopus.com/inward/record.url?scp=0030811906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030811906&partnerID=8YFLogxK

U2 - 10.1258/0956462971920794

DO - 10.1258/0956462971920794

M3 - Article

C2 - 9292345

AN - SCOPUS:0030811906

VL - 8

SP - 563

EP - 569

JO - International Journal of STD and AIDS

JF - International Journal of STD and AIDS

SN - 0956-4624

IS - 9

ER -